RELEASE ISSUED BY: ECOG-ACRIN CANCER RESEARCH GROUP
September 28, 2015—VIENNA and PHILADELPHIA and REDWOOD CITY, Calif.)—Initial results were announced today from the Trial Assigning Individualized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer ...read more
Rapid Blood Test for TB Shows Promise—The key goals of tuberculosis control—preventing and reducing transmission—both require prompt diagnosis and initiation of treatment. But existing diagnostic tests can be time-consuming and require not-always-available sputum samples for detecting TB bacteria that might be present. In a new study, Dr. Jacqueline Achkar demonstrated that a panel of eight protein biomarkers in the... read more
Insights into Pediatric Cerebral Malaria—Some 450,000 children die of malaria each year, with half those deaths from cerebral malaria (CM), a condition in which parasite-filled red blood cells clog the brain¹s blood vessels, causing brain swelling and coma. A research team led by Dr. Kami Kim worked with investigators at the Blantyre Malaria Project to examine brain tissue from... read more
Understanding an Anti-Cancer Mechanism—In response to mutagenic activation of an oncogene, cells respond with a mechanism called oncogene-induced senescence (OIS). In addition to causing a stable arrest of proliferation, OIS triggers a complex pro-inflammatory response called the Senescence-Associated Secretory Phenotype (SASP), which can signal the immune system to clear pre-cancerous cells. Dr. Matthew Gamble has discovered that a molecule called macroH2A1... read more
Two recent studies from Einstein-Montefiore faculty spotlight the benefits of the intrauterine device (IUD), an extremely effective contraceptive that is underused by American women.
Dr. Michler is a heart surgeon who specializes in complex aortic and mitral valve repair surgery. He is an NIH-funded ...read more